| Supramolecular amplification of amyloid self-assembly by iodination A Bertolani, L Pirrie, L Stefan, N Houbenov, JS Haataja, L Catalano, ... Nature Communications 6 (1), 7574, 2015 | 101 | 2015 |
| Implementation of value-based pricing for medicines C Jommi, P Armeni, F Costa, A Bertolani, M Otto Clinical therapeutics 42 (1), 15-24, 2020 | 63 | 2020 |
| An efficient method for the lipase-catalysed resolution and in-line purification of racemic flurbiprofen in a continuous-flow reactor L Tamborini, D Romano, A Pinto, A Bertolani, F Molinari, P Conti Journal of Molecular Catalysis B: Enzymatic 84, 78-82, 2012 | 60 | 2012 |
| La spesa sanitaria: composizione ed evoluzione P Armeni, A Bertolani, L Borsoi, F Costa Rapporto OASI 2018, 119-178, 2018 | 53 | 2018 |
| Halogen bonding modulates hydrogel formation from Fmoc amino acids A Pizzi, L Lascialfari, N Demitri, A Bertolani, D Maiolo, E Carretti, ... CrystEngComm 19 (14), 1870-1874, 2017 | 41 | 2017 |
| Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects C Rognoni, A Bertolani, C Jommi Clinical Drug Investigation 41, 303-319, 2021 | 37 | 2021 |
| Crystal structure of the DFNKF segment of human calcitonin unveils aromatic interactions between phenylalanines A Bertolani, A Pizzi, L Pirrie, L Gazzera, G Morra, M Meli, G Colombo, ... Chemistry–A European Journal 23 (9), 2051-2058, 2017 | 28 | 2017 |
| Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives C Rognoni, A Bertolani, C Jommi Global & Regional Health Technology Assessment 2018, 2284240318784289, 2018 | 13 | 2018 |
| Local policies on biosimilars: are they designed to optimize use of liberated resources A Bertolani, C Jommi Generics and Biosimilars Journal (GaBI) 9 (4), 163-170, 2020 | 12 | 2020 |
| The hospitalization burden of influenza: just the tip of the iceberg? A Bertolani, G Fattore, F Pregliasco Global & Regional Health Technology Assessment 2018, 2284240318777148, 2018 | 10 | 2018 |
| La ricerca clinica in Italia: quanto, come viene finanziata e suoi effetti sul sistema M Cavazza, A Bertolani, C Jommi Il valore della ricerca clinica indipendente in Italia: Libro Bianco sulla …, 2019 | 5 | 2019 |
| Politiche del farmaco ed impatto sulla spesa: gli effetti di quindici anni di decentramento nel SSN, con un focus sull’adozione di forme alternative di distribuzione dei farmaci P Armeni, A Bertolani, F Costa, C Jommi, M Otto Rapporto OASI 2017, 503-533, 2017 | 5 | 2017 |
| Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe C Jommi, A Bertolani, P Armeni, F Costa, M Otto Health Policy and Technology 12 (3), 100771, 2023 | 3 | 2023 |
| L'acquisto di farmaci in Italia: l'effetto di approcci selettivi P Armeni, A Bertolani, F Costa, M Otto, C Jommi Rapporto OASI 2018, 611-648, 2018 | 3 | 2018 |
| Il futuro dei Fondi per Farmaci Innovativi: risultati di uno studio basato su Delphi panel C Jommi, P Armeni, A Bertolani, F Costa, M Otto Global & Regional Health Technology Assessment 8, 22, 2021 | 2 | 2021 |
| The future of Funds for Innovative Medicines: results from a Delphi Study C Jommi, P Armeni, A Bertolani, F Costa, M Otto GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT 8, 22-28, 2021 | 2 | 2021 |
| Patients’ Associations and HTA for medicines: actual and future role in Italy C Jommi, A Bertolani Global & Regional Health Technology Assessment 2018, 2284240318770966, 2018 | 1 | 2018 |
| Il costo a carico dei pazienti del percorso per eleggibilità ai farmaci PCSK9 e follow-up di un anno: i risultati dello Studio PRIOR A Bertolani, R Ravasio, P Raimondo, C Jommi Global & Regional Health Technology Assessment 9, 73, 2022 | | 2022 |
| The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study A Bertolani, R Ravasio, P Raimondo, C Jommi Global and Regional Health Technology Assessment 9, 73-81, 2022 | | 2022 |
| PBI35 Local Policies on Biosimilars: Are They Designed to Optimize Use of Freed Resources? C Jommi, A Bertolani Value in Health 23, S416, 2020 | | 2020 |
Giancarlo TerraneoPolitecnico di MilanoVerified email at polimi.it
